Influenza Diagnostics Market: Information by Test Type (Traditional Diagnostic Tests), Influenza Type (Influenza A, Influenza B), Distribution Channel, and Region — Forecast till 2029

Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Global Influenza Diagnostics Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

3.6       Technological Overview

3.7       Top investment pockets

3.7       Impact of COVID-19 on Influenza Diagnostics Market

4          Test Type Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Traditional Diagnostic Test

4.2.1   Market Size & Forecast (Value)

4.2.1.1            RIDT

4.2.1.2            Viral Culture

4.2.1.3            DFA

4.2.1.4            Serological assays

4.3       Molecular Diagnostic Test

4.3.1   Market Size & Forecast (Value)

4.3.1.1            RT-PCR

4.3.1.2            INNAT

4.3.1.2.1         TMA

4.3.1.2.2         LAMP

4.3.1.2.3         NASBA

4.3.1.2.4         Other INNAT

4.3.1.3            Other Molecular Tests

5          Influenza Type Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Influenza A

5.2.1   Market Size & Forecast (Value)

5.3       Influenza B

5.3.1   Market Size & Forecast (Value)

6          End User Overview

6.1       Introduction

6.1.1   Market Size & Forecast (Value)

6.2       Hospitals

6.2.1   Market Size & Forecast (Value)

6.3       Point-of-Care Testing

6.3.1   Market Size & Forecast (Value)

6.4       Diagnostic Centers

6.4.1   Market Size & Forecast (Value)

6.5       Others

6.5.1   Market Size & Forecast (Value)

7          Regional Overview

7.1      Introduction

7.1.1   Market Size & Forecast (Value)

7.2      America

7.2.1   North America

7.2.1.1      The U.S.

7.2.1.1.1         By Test Type

7.2.1.1.2         By Influenza Type

7.2.1.2      Canada

7.2.1.2.1         By Test Type

7.2.1.2.2         By Influenza Type

7.2.1.3      Mexico

7.2.1.3.1         By Test Type

7.2.1.3.2         By Influenza Type

7.2.2   Central, South America and the Caribbean

7.2.2.1      By Test Type

7.2.2.2      By Influenza Type

7.2.2.2.1   Brazil

7.2.2.2.1.1      By Test Type

7.2.2.2.1.2      By Influenza Type

7.2.2.2.2   Argentina

7.2.2.2.2.1      By Test Type

7.2.2.2.2.2      By Influenza Type

7.2.2.2.3   The Rest ofCentral, South America and Caribbean

7.2.2.2.3.1      By Test Type

7.2.2.2.3.2      By Influenza Type

7.3      Europe

7.3.1   Market Size & Forecast (Value)

7.3.2   Western Europe

7.3.2.1      The U.K

7.3.2.1.1         By Test Type

7.3.2.1.2         By Influenza Type

7.3.2.2      Germany

7.3.2.2.1         By Test Type

7.3.2.2.2         By Influenza Type

7.3.2.3      France

7.3.2.3.1         By Test Type

7.3.2.3.2         By Influenza Type

7.3.2.4      Spain

7.3.2.4.1         By Test Type

7.3.2.4.2         By Influenza Type

7.3.2.5      Italy

7.3.2.5.1         By Test Type

7.3.2.5.2         By Influenza Type

7.3.2.6      The Rest of Western Europe

7.3.2.6.1         By Test Type

7.3.2.6.2         By Influenza Type

7.3.3   Eastern Europe

7.3.3.1  By Test Type

7.3.3.2  By Influenza Type

7.3.4   The Rest of Europe

7.3.4.1  By Test Type

7.3.4.2  By Influenza Type

7.4      AsiaPacific

7.4.1   Market Size & Forecast (Value)

7.4.2   Japan

7.4.2.1            By Test Type

7.4.2.2            By Influenza Type

7.4.3   China

7.4.3.1            By Test Type

7.4.3.1            By Influenza Type

7.4.4   Australia

7.4.4.1            By Test Type

7.4.4.2            By Influenza Type

7.4.5   India

7.4.5.1            By Test Type

7.4.5.2            By Influenza Type

7.4.6   South Korea

7.4.6.1            By Test Type

7.4.6.2            By Influenza Type

7.4.7   The Rest of Asia-Pacific

7.4.7.1            By Test Type

7.4.7.2            By Influenza Type

7.7      The Middle East & Africa

7.7.1   The Middle East

7.7.1.1            Market Size & Forecast (Value)

7.7.1.2            Saudi Arabia

7.7.1.2.1         By Test Type

7.7.7.2.2         By Influenza Type

7.7.1.3            The UAE

7.7.1.3.1         By Test Type

7.7.1.3.2         By Influenza Type

7.7.1.4            Qatar

7.7.1.4.1         By Test Type

7.7.1.4.2         By Influenza Type

7.7.2 Africa

7.7.2.1            Market Size & Forecast (Value)

8          Company Profile

8.1      F. Hoffmann-La Roche AG

8.1.1   Company Overview

8.1.2   Financial Performance

8.1.3   Recent Developments

8.1.4   Test TypePortfolio

8.2      Quidel Corporation

8.2.1   Company Overview

8.2.2   Financial Performance

8.2.3   Recent Developments

8.2.4   Test TypePortfolio

8.3      Thermo Fisher Scientific

8.3.1   Company Overview

8.3.2   Financial Performance

8.3.3   Recent Developments

8.3.4   Test TypePortfolio

8.4      Abbott Laboratories

8.4.1   Company Overview

8.4.2   Financial Performance

8.4.3   Recent Developments

8.4.4   Test TypePortfolio

8.5      Hologic

8.5.1   Company Overview

8.5.2   Financial Performance

8.5.3   Recent Developments

8.5.4   Test TypePortfolio

8.6      Becton, Dickinson, and Company

8.6.1   Company Overview

8.6.2   Financial Performance

8.6.3   Recent Developments

8.6.4   Test TypePortfolio

8.7      DiaSorinS.p.A

8.7.1   Company Overview

8.7.2   Financial Performance

8.7.3   Recent Developments

8.7.4   Test TypePortfolio

8.8      Luminex Corporation

8.8.1   Company Overview

8.8.2   Financial Performance

8.8.3   Recent Developments

8.8.4   Test TypePortfolio

8.9      Meridian Bioscience

8.9.1   Company Overview

8.9.2   Financial Performance

8.9.3   Recent Developments

8.9.4   Test TypePortfolio

8.10    GenMark Diagnostics

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test TypePortfolio

8.11    SA Scientific

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test Type Portfolio

8.12    bioMérieux SA

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test Type Portfolio

8.13    Danaher Corporation

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test Type Portfolio

8.14    Siemens Healthineers

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test Type Portfolio

8.15    altona Diagnostics

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test Type Portfolio

8.16    CorisBioConcept

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test Type Portfolio

8.16    Others

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Test Type Portfolio

9          Conclusion & Recommendations

10        Acronyms & Abbreviations

 

Report Description Download Sample

Copyright . All rights Reserved By Straits Research